These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple, Hewlett-Packard, Qualcomm and Sprouts Farmers Market.
ThinkstockVIVUS Inc. (NASDAQ: VVUS) investors have a lot to be disappointed about these days. America’s ballooning waistline is reaching a critical level, yet VIVUS did not even manage to close up one…
Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Here are the seven top biopharma stocks to buy now, according to Piper Jaffray.
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
Jon OggWith the government shut down and with the debt ceiling debate breathing down everyone’s neck, investors have to be wondering what they should buy, sell and hold (or even avoid). Stocks…
ThinkstockAs a rule, Wall Street brokers and financial advisors typically try to steer their clients away from stocks that trade under $10, as well as avoid like the plague stocks that trade…
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems…
ThinkstockDrug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States last June.…
ThinkstockMuch of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable to investors…
ThinkstockVIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug Qsymia. Its…
ThinkstockIf you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned way through…
ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, stroke, type-2…
ThinkstockArena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% on news…
ThinkstockBack in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a battle of…
ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes and even…
